MARKET INTRODUCTION
Medical inhalers are medical devices that are used for delivering various medication via inhalation. The medications used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. Smart inhalers are a type of medical inhalers having sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data obtained by the sensor is shared with the patient and healthcare professionals to track their inhaler usage. Other different types of inhalers include dry powder inhaler, metered-dose inhaler, and others.
MARKET DYNAMICS
The medical inhalers market has shown a significant evolution over the forecast period. The rise of the medical inhalers market is driven by the increased prevalence of people suffering from asthma and chronic obstructive pulmonary diseases and technological advancements in developing better smart inhaler devices and systems. Moreover, government initiatives toward improvising standard healthcare infrastructure and increased focus on healthcare expenditure are helping these countries to focus on offering high-quality healthcare. Elaborate efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder (COPD), which affects the majority of the people. According to WHO, more than 300 million people in the world are affected by asthma, and more than 200 million people are affected by COPD by 2016. However, the higher cost associated with medical inhalers' development for asthma and COPD is expected to restrain the medical inhalers market growth.
MARKET SCOPE
The "Medical Inhalers Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's medical device, focusing on the global market trend analysis. This report outlines the medical inhalers market with detailed market segmentation by product, application, and end-user. The medical inhalers market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on the leading players' market status in the medical inhalers market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as dry powder inhaler, metered dose inhaler, and others. Based on the application, the segmentation of the market is into asthma, chronic obstructive pulmonary disorder, others. Based on end user, the segmentation of the market is into hospitals, clinics, respiratory care center, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the medical inhalers market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The medical inhalers market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the medical inhalers market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Medical inhalers market in these regions.
MARKET PLAYERS
The report contains critical developments in the medical inhalers market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the medical inhalers market are estimated to have profitable growth opportunities in the coming years with the higher demand for medical inhalers in the global market. Given below is the list of a few companies engaged in the medical inhalers market.
The report also offers key players' profiles in the medical inhalers market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- GlaxoSmithKline plc.
- Koninklijke Philips N.V.
- AstraZeneca
- Cipla Inc.
- Boehringer Ingelheim International GmbH
- Beximco Pharmaceuticals Ltd
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd
- Chiesi Farmaceutici SpA
- Medisol Lifescience Pvt. Ltd
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.